Healthcare resource utilization and costs among women diagnosed with uterine fibroids compared to women without uterine fibroids-Reference-Cited by-同舟云学术

Healthcare resource utilization and costs among women diagnosed with uterine fibroids compared to women without uterine fibroids

Published:2019-08-22 Issue:11 Volume:35 Page:1925-1935
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Shih Vanessa¹,Banks Erika²,Bonine Nicole G.³,Harrington Amanda¹,Stafkey-Mailey Dana⁴,Yue Binglin⁴,Ye Jiatao Michael⁵,Fuldeore Rupali M.⁶,Gillard Patrick¹

Affiliation:

1. Allergan plc, Irvine, CA, USA;

2. Albert Einstein College of Medicine, Bronx, NY, USA;

3. Allergan plc, Markham, ON, Canada;

4. Xcenda LLC, Palm Harbor, FL, USA;

5. Allergan plc, Madison, NJ, USA;

6. Astellas Pharma US, Inc., Northbrook, IL, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2019.1642186

Reference19 articles.

1. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence

2. Uterine Fibroids

3. Uterine fibroids

4. American Society for Reproductive Medicine. Abnormal Uterine Bleeding. A Guide for Patients [Internet]. 2012 [cited 2018 Jul 18]. Available from: https://www.reproductivefacts.org/globalassets/rf/news-and-publications/bookletsfact-sheets/english-fact-sheets-and-info-booklets/Abnormal_Uterine_Bleeding.pdf

5. ACOG Practice Bulletin No. 96: Alternatives to Hysterectomy in the Management of Leiomyomas

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uterine leiomyomata claim rate estimates and demographic characteristics by county. Florida, 2010–2019;Women & Health;2023-12-28

2. Sintomatología e impacto clínico;Medicina Clínica;2023-10

3. Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study;BMC Public Health;2023-05-19

4. MED12 mutations in uterine leiomyomas: prediction of volume reduction by gonadotropin-releasing hormone agonists;American Journal of Obstetrics and Gynecology;2023-02

5. Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: An age- period-cohort analysis for the Global Burden of Disease 2019 study;2022-12-09